Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter Study

Blood Purif. 2017;43(4):338-345. doi: 10.1159/000453442. Epub 2017 Mar 2.

Abstract

Background: Oxidative stress has been related to hypo-response to erythropoiesis-stimulating agents (ESAs) in hemodialysis (HD) patients. The aim of this study was to verify whether vitamin E (ViE) on a synthetic polysulfone dialyzer can improve ESA responsiveness.

Methods: This controlled, multicenter study involved 93 HD patients on stable ESA therapy, who were randomized to either ViE-coated polysulfone dialyzer or to a low-flux synthetic dialyzer. The primary outcome measure was the change in ESA resistance index (ERI) from baseline.

Results: Mean ERI decreased in the ViE group by 1.45 IU/kg*g/dl and increased in the control group by 0.53 IU/kg*g/dl, with a mean difference of 1.98 IU/kg*g/dl (p = 0.001 after adjusting for baseline ERI, as foreseen by the study protocol). Baseline ERI was inversely related to its changes during follow-up only in the control group (R2 = 0.29).

Conclusions: The ViE dialyzer can improve ESA response in HD patients. Changes in ERI during follow-up are independent from baseline ERI only in the ViE group. Video Journal Club 'Cappuccino with Claudio Ronco' at http://www.karger.com/?doi=453442.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Anemia / blood
  • Anemia / drug therapy*
  • Anemia / etiology
  • Erythropoietin / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Kidney Function Tests
  • Male
  • Membranes, Artificial*
  • Middle Aged
  • Renal Dialysis* / adverse effects
  • Renal Dialysis* / methods
  • Treatment Outcome
  • Vitamin E* / chemistry

Substances

  • Membranes, Artificial
  • Erythropoietin
  • Vitamin E